Yang F, Liu G, Mao F, Zheng YC, et al. Re: Pathologic complete responses, long-term outcomes, and recurrence patterns in HER2-low vs. HER2-zero breast cancer after neoadjuvant chemotherapy: Several issues about HER2 expression and neoadjuvant chemotherapy in breast cancer. Eur J Cancer 2022 Dec 27:S0959-8049(22)01763-4. doi: 10.1016/j.ejca.2022.
PMID: 36581473